NFE2L2 and early-onset autosomal dominant Alzheimer disease: PI3K/AKT signaling was elucidated to also promote the activation of Nrf2 signaling in Alzheimer’s disease (Lin et al. 2022) and traumatic brain injury (Cheng et al. 2023).